T1	PROC 44 88	Estudio para evaluar la eficacia y seguridad
T2	DISO 120 136	Colitis ulcerosa
#1	AnnotatorNotes T2	C0009324; Ulcerative Colitis; Disease or Syndrome
T3	PROC 188 205	terapia biológica
#2	AnnotatorNotes T3	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T4	PROC 235 307	Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo
T5	PROC 313 344	evaluar la eficacia y seguridad
#3	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	DISO 378 394	colitis ulcerosa
#4	AnnotatorNotes T6	C0009324; Ulcerative Colitis; Disease or Syndrome
T7	PROC 443 460	terapia biológica
#5	AnnotatorNotes T7	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T8	DISO 491 507	Colitis Ulcerosa
#6	AnnotatorNotes T8	C0009324; Ulcerative Colitis; Disease or Syndrome
T9	PROC 768 779	Diagnóstico
#7	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	DISO 794 810	colitis ulcerosa
#8	AnnotatorNotes T10	C0009324; Ulcerative Colitis; Disease or Syndrome
T11	DISO 812 814	CU
#9	AnnotatorNotes T11	C0009324; Ulcerative Colitis; Disease or Syndrome
T12	DISO 871 887	Colitis Ulcerosa
#10	AnnotatorNotes T12	C0009324; Ulcerative Colitis; Disease or Syndrome
T13	PROC 957 976	terapias biológicas
#11	AnnotatorNotes T13	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T14	PROC 1023 1034	diagnostico
#12	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 1045 1064	Enfermedad de Crohn
#13	AnnotatorNotes T15	C0010346; Crohn Disease; Disease or Syndrome
T16	DISO 1066 1068	EC
#14	AnnotatorNotes T16	C0010346; Crohn Disease; Disease or Syndrome
T17	DISO 1071 1120	Enfermedad del intestino inflamado no clasificado
#15	AnnotatorNotes T17	C4268603; Colonic inflammatory bowel disease unclassified (IBDU); Disease or Syndrome
T18	DISO 1122 1127	IBD-U
T19	DISO 1158 1175	colitis isquémica
#16	AnnotatorNotes T19	C0162529; Colitis, Ischemic; Disease or Syndrome
T20	CHEM 1219 1229	medicación
#17	AnnotatorNotes T20	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T21	PROC 1242 1253	tratamiento
#18	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	DISO 1269 1292	Enfermedad Inflamatoria
T23	ANAT 1305 1310	recto
#19	AnnotatorNotes T23	C0034896; Rectum; Body Part, Organ, or Organ Component | C1278926; Entire rectum; Body Part, Organ, or Organ Component
T24	PROC 1330 1353	endoscopia de screening
#20	AnnotatorNotes T24	C1882982; Screening colonoscopy; Diagnostic Procedure
T25	DISO 1369 1383	complicaciones
#21	AnnotatorNotes T25	C0009566; Complication; Pathologic Function
T26	DISO 1406 1422	colitis ulcerosa
#22	AnnotatorNotes T26	C0009324; Ulcerative Colitis; Disease or Syndrome
T27	DISO 1424 1426	CU
#23	AnnotatorNotes T27	C0009324; Ulcerative Colitis; Disease or Syndrome
T28	CHEM 348 360	Risankizumab
#24	AnnotatorNotes T28	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T29	CHEM 92 104	Risankizumab
#25	AnnotatorNotes T29	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	DISO 898 910	Intolerancia
#26	AnnotatorNotes T30	C0277585; Intolerance to drug; Pathologic Function
T31	ANAT 1086 1095	intestino
#27	AnnotatorNotes T31	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T32	PROC 1146 1155	radiación
#28	AnnotatorNotes T32	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T33	Date 12 16	2016
T34	LIVB 108 115	sujetos
#29	AnnotatorNotes T34	C0681850; Study Subject; Group
T35	LIVB 364 373	pacientes
#30	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 545 552	mujeres
#31	AnnotatorNotes T36	C0043210; Woman; Population Group
T37	Age 562 579	>=18 a <= 80 años
T38	LIVB 649 658	pacientes
#32	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Age 659 676	de 16 a < 18 años
T40	Duration 824 840	al menos 3 meses
T41	LIVB 1006 1015	Pacientes
#33	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Date 1035 1041	actual
T45	LIVB 1180 1197	Sujetos pacientes
#34	AnnotatorNotes T45	C0681850; Study Subject; Group + C0030705; Patients; Patient or Disabled Group
T46	LIVB 1357 1364	Sujetos
#35	AnnotatorNotes T46	C0681850; Study Subject; Group
T47	Date 1384 1392	actuales
T43	LIVB 535 542	Hombres
#36	AnnotatorNotes T43	C0025266; Male population group; Population Group
T44	Neg_cue 1258 1268	Exentos de
T48	PROC 739 745	Tanner
#37	AnnotatorNotes T48	C0431029; Tanner bone age assessment; Diagnostic Procedure
T49	PROC 854 860	visita
#38	AnnotatorNotes T49	C1512346; Patient Visit; Health Care Activity
T50	PROC 752 758	visita
#39	AnnotatorNotes T50	C1512346; Patient Visit; Health Care Activity
T51	Quantifier_or_Qualifier 759 764	basal
#40	AnnotatorNotes T51	C1442488; Baseline; Quantitative Concept
T52	Quantifier_or_Qualifier 861 866	basal
#41	AnnotatorNotes T52	C1442488; Baseline; Quantitative Concept
A1	Assertion T22 Negated
A2	Assertion T20 Contraindicated
A3	Status T3 History_of
A4	Status T7 History_of
A5	Status T30 History_of
A6	Status T32 History_of
A7	Status T19 History_of
A8	Status T25 History_of
#42	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#43	AnnotatorNotes T4	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#44	AnnotatorNotes T18	C4268603; Colonic inflammatory bowel disease unclassified (IBDU); Disease or Syndrome
#45	AnnotatorNotes T22	C1290884; Inflammatory disorder; Disease or Syndrome 
#46	AnnotatorNotes T42	C0521116; Current (present time); Temporal Concept 
#47	AnnotatorNotes T47	C0521116; Current (present time); Temporal Concept 
T53	Quantifier_or_Qualifier 1109 1120	clasificado
A9	Assertion T53 Negated
#48	AnnotatorNotes T53	C0008902; Classification; Classification
T54	Neg_cue 1106 1108	no
R1	Experiences Arg1:T34 Arg2:T29	
R2	Experiences Arg1:T34 Arg2:T2	
T55	Quantifier_or_Qualifier 140 157	moderada a severa
#49	AnnotatorNotes T55	C1299393; Moderate to severe; Qualitative Concept
R3	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T55	
T56	Quantifier_or_Qualifier 405 421	moderada a grave
#50	AnnotatorNotes T56	C1299393; Moderate to severe; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T56	
T57	Quantifier_or_Qualifier 158 164	activa
#51	AnnotatorNotes T57	C0679217; Active State; Idea or Concept
R5	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T57	
T58	Quantifier_or_Qualifier 395 401	activa
#52	AnnotatorNotes T58	C0679217; Active State; Idea or Concept
R6	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T58	
T59	Quantifier_or_Qualifier 888 894	activa
#53	AnnotatorNotes T59	C0679217; Active State; Idea or Concept
R7	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T59	
R8	Has_Duration_or_Interval Arg1:T11 Arg2:T40	
R9	Before Arg1:T11 Arg2:T49	
R10	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T52	
R11	Before Arg1:T10 Arg2:T49	
R12	Has_Duration_or_Interval Arg1:T10 Arg2:T40	
R13	Before Arg1:T9 Arg2:T49	
T60	Observation 924 944	respuesta inadecuada
#54	AnnotatorNotes T60	C0858218; Inappropriate drug response; Finding
R14	Overlap Arg1:T60 Arg2:T13	
R15	Causes Arg1:T13 Arg2:T30	
R16	Experiences Arg1:T34 Arg2:T3	
T61	Observation 174 181	fallado
#55	AnnotatorNotes T61	C0162643; treatment failure; Finding
R17	Experiences Arg1:T34 Arg2:T61	
R18	Before Arg1:T3 Arg2:T61	
T62	Observation 430 437	fallado
#56	AnnotatorNotes T62	C0162643; treatment failure; Finding
R19	Before Arg1:T7 Arg2:T62	
R20	Experiences Arg1:T35 Arg2:T6	
R21	Experiences Arg1:T35 Arg2:T28	
R22	Experiences Arg1:T35 Arg2:T62	
R23	Experiences Arg1:T35 Arg2:T7	
R24	Has_Age Arg1:T36 Arg2:T37	
R25	Has_Age Arg1:T43 Arg2:T37	
R26	Has_Age Arg1:T38 Arg2:T39	
T63	Result_or_Value 711 720	estadio 5
R27	Has_Result_or_Value Arg1:T48 Arg2:T63	
R28	Experiences Arg1:T38 Arg2:T48	
R29	Overlap Arg1:T48 Arg2:T50	
R30	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T51	
R31	Overlap Arg1:T14 Arg2:T42	
R32	Overlap Arg1:T15 Arg2:T42	
R33	Overlap Arg1:T16 Arg2:T42	
R34	Location_of Arg1:T31 Arg2:T17	
R35	Experiences Arg1:T41 Arg2:T15	
R36	Experiences Arg1:T41 Arg2:T16	
R37	Experiences Arg1:T41 Arg2:T17	
R38	Experiences Arg1:T41 Arg2:T18	
R39	Experiences Arg1:T41 Arg2:T32	
R40	Experiences Arg1:T41 Arg2:T19	
R41	Location_of Arg1:T31 Arg2:T18	
R42	Overlap Arg1:T17 Arg2:T42	
R43	Overlap Arg1:T18 Arg2:T42	
R45	Experiences Arg1:T45 Arg2:T21	
R46	Negation Arg1:T44 Arg2:T22	
R47	Location_of Arg1:T23 Arg2:T22	
T64	Quantifier_or_Qualifier 1293 1310	limitada al recto
R49	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T64	
A10	Assertion T64 Negated
R50	Negation Arg1:T44 Arg2:T64	
R51	Overlap Arg1:T25 Arg2:T47	
R52	Experiences Arg1:T46 Arg2:T25	
R53	Experiences Arg1:T46 Arg2:T26	
R54	Experiences Arg1:T46 Arg2:T27	
R55	Causes Arg1:T26 Arg2:T25	
R56	Causes Arg1:T27 Arg2:T25	
R44	Before Arg1:T3 Arg2:T29	
R57	Before Arg1:T7 Arg2:T28	
R58	Experiences Arg1:T38 Arg2:T50	
R59	Negation Arg1:T54 Arg2:T53	
R60	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T53	
R61	Experiences Arg1:T45 Arg2:T20	
A11	Experiencer T45 Patient
A12	Experiencer T46 Patient
A13	Experiencer T34 Patient
A14	Experiencer T35 Patient
A15	Experiencer T43 Patient
A16	Experiencer T36 Patient
A17	Experiencer T38 Patient
A18	Experiencer T41 Patient
